Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

Jemal, 2010, Cancer statistics 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073

Pisters, 1996, Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities, J Clin Oncol, 14, 1679, 10.1200/JCO.1996.14.5.1679

Bramwell, 1994, Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma—reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, J Clin Oncol, 12, 1137, 10.1200/JCO.1994.12.6.1137

Steward, 1993, Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, J Clin Oncol, 11, 15, 10.1200/JCO.1993.11.1.15

Trojani, 1984, Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system, Int J Cancer, 33, 37, 10.1002/ijc.2910330108

Woll, 2007, Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial, Proc Am Soc Clin Oncol, 25, 10008, 10.1200/jco.2007.25.18_suppl.10008

Santoro, 1995, Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, J Clin Oncol, 13, 1537, 10.1200/JCO.1995.13.7.1537

Le Cesne, 2000, J Clin Oncol, 18, 2676, 10.1200/JCO.2000.18.14.2676

1997, Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data, Lancet, 350, 1647, 10.1016/S0140-6736(97)08165-8

Brodowicz, 2000, Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial, Sarcoma, 4, 151, 10.1155/2000/126837

Fakhrai, 2010, Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial, Wien Klin Wochenschr, 122, 614, 10.1007/s00508-010-1472-4

Frustaci, 2001, Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian Randomized Cooperative trial, J Clin Oncol, 19, 1238, 10.1200/JCO.2001.19.5.1238

Frustaci, 2003, Ifosfamide in the adjuvant therapy of soft tissue sarcomas, Oncology, 65, 80, 10.1159/000073366

Petrioli, 2002, Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma, Am J Clin Oncol, 25, 468, 10.1097/00000421-200210000-00009

Mantel, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186

Higgins, 2003, Measuring inconsistency in meta analyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557

Pignon, 2008, Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group, J Clin Oncol, 26, 3552, 10.1200/JCO.2007.13.9030

Pervaiz, 2008, A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma, Cancer, 113, 573, 10.1002/cncr.23592

Gortzak, 2001, A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma, Eur J Cancer, 37, 1096, 10.1016/S0959-8049(01)00083-1

Issels, 2010, Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study, Lancet Oncol, 11, 561, 10.1016/S1470-2045(10)70071-1